Literature DB >> 29922473

Molecular characterization of KPC-2-positive Klebsiella pneumoniae isolates from a neurosurgical centre in Argentina.

S Montaña1, M Hernandez2, J S Fernandez2, M Pennini3, D Centrón1, A Sucari3, A Iriarte4, M S Ramírez2.   

Abstract

Carbapenem-resistant Enterobacteriaceae is a growing concern worldwide. Klebsiella pneumoniae is an important nosocomial pathogen with a high capacity for nosocomial spread. We described the occurrence of plasmid-encoded KPC-2-harbouring K. pneumoniae isolates recovered from a neurosurgical centre in Argentina. The blaKPC-2 gene was surrounded by ISkpn6 and ISkpn7.

Entities:  

Keywords:  Klebsiella pneumoniae; bla; carbapenem resistance; neurosurgical centre

Year:  2018        PMID: 29922473      PMCID: PMC6004774          DOI: 10.1016/j.nmni.2018.04.002

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


Klebsiella pneumoniae is an important nosocomial pathogen involved in urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, surgical-wound infection, bacteraemia and septicaemia [1], [2]. It is well known that carbapenem-resistant Enterobacteriaceae (CRE) is a growing concern worldwide [3]. In recent years, the ongoing emergence of CRE in Argentina has increased and among them, K. pneumoniae harbouring K. pneumoniae carbapenemase (KPC) are prevalent [4]. KPCs are the most frequent carbapenemases found in K. pneumoniae and in many other members of the Enterobacteriaceae family such as Escherichia coli, Enterobacter spp., Salmonella enterica, Proteus mirabilis and Citrobacter freundii [5]. Because the blaKPC-2 gene is mostly plasmid encoded [6], [7], [8] and is typically in a Tn3-based transposon, Tn4401, the capacity of disseminating among K. pneumoniae and in Gram-negative genera is a major concern [2], [3]. K. pneumoniae sequence type (ST) 258 is largely responsible for KPC dissemination throughout North America and other parts of the world. No information describing K. pneumoniae KPC-positive isolates or KPC outbreaks in neurosurgical centres can be found in the literature. Only one report describing a KPC-2–producing Klebsiella pneumoniae outbreak in patients admitted to a neurosurgery department in a South Korean has been published [9]. The aim of this study was to perform the molecular characterization of the genetic surroundings of the blaKPC-2 gene among K. pneumoniae (KPC-2 positive) clinical isolates recovered from 70 subjects tested in a neurosurgical centre in Argentina. During 2014–2016, a total of 22 nonrepeated carbapenem-resistant K. pneumoniae KPC-positive isolates were recovered from a variety of samples including blood, urine and respiratory tract. Antibiotic susceptibility was determined using the VITEK 2 System (bioMérieux, Marcy l'Etoile, France) using the panel AST-082 (GNS susceptibility card) and interpreted using the Clinical and Laboratory Standards Institute (CLSI) categories, with the exception of colistin and tigecycline, where the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations was used. The blaKPC gene was identified by PCR amplification and subsequently sequenced to confirm the variant present in the isolates. The absence of other carbapenemases (bla, blaNDM-1 and blaOXA-48) was confirmed by PCR. Conjugation assays were performed to determine the genetic location of the gene [10]. All the strains possessed similar antibiotic susceptibility profiles and harboured blaKPC-2 in conjugative plasmids (Table 1).
Table 1

Study strains

StrainMaterial sourceAntibiotic profileaKPC PCR
KPC 2Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, COLPositive
KPC 3Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 4Respiratory secretionMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, TIGPositive
KPC 5Blood cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, TIGPositive
KPC 6Bronchoalveolar lavageMEM, IMP, ERT, TMSPositive
KPC 8Cerebrospinal fluidMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositive
KPC 9Urine cultureMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositive
KPC 11Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 13Urine cultureMEM, IMP, ERT, GEN, AKN, TMS, CIP, COL, TIGPositive
KPC 16Blood cultureMEM, IMP, ERT, TMS, CIP, FOS, COL, TIGPositive
KPC 17Urine cultureMEM, IMP, ERT, TMS, CIPPositive
KPC 18CatheterMEM, IMP, ERTPositive
KPC 19Anal swabMEM, IMP, ERT, TMS, CIPPositive
KPC 20Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 21Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 22Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 23Anal swabMEM, IMP, ERT, TMS, CIPPositive
KPC 24CatheterMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 25Anal swabMEM, IMP, ERT, GEN, AKN, TMS, CIP, FOS, COL, TIGPositive
KPC 26Urine cultureMEM, IMP, ERT, GEN, TMS, CIP, FOS, TIGPositive
KPC 27Respiratory secretionMEM, IMP, ERT, GEN, TMS, CIP, FOS, TIGPositive

AMK, amikacin; CIP, ciprofloxacin; COL, colistin; ERT, ertapenem; FOS, fosfomycin; GEN, gentamicin; IMP, imipenem; KPC, Klebsiella pneumoniae carbapenemase; MEM, meropenem; TIG, tigecycline; TMS, trimethoprim/sulfamethoxazole.

Resistance only.

Study strains AMK, amikacin; CIP, ciprofloxacin; COL, colistin; ERT, ertapenem; FOS, fosfomycin; GEN, gentamicin; IMP, imipenem; KPC, Klebsiella pneumoniae carbapenemase; MEM, meropenem; TIG, tigecycline; TMS, trimethoprim/sulfamethoxazole. Resistance only. To further characterize in detail the genetic context of blaKPC-2, one strain was randomly selected (Kpn8). Plasmid extraction was performed using the QIAfilter Midi prep Kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. Whole-plasmid shotgun sequencing was performed using Illumina MiSeq-I, with Nextera XT libraries for sample preparation (Illumina, San Diego, CA, USA). Assemblies were annotated by means of the RAST Server [11] and the SEED source for plasmid annotations [12]. The genetic analysis of the blaKPC-2 gene revealed the presence of ISkpn6 and ISkpn7 flanking this gene (Fig. 1). This structure was disrupting the transposon Tn4401. Moreover, an incomplete copy of ISkpn31 and a part of Tn5403 were present downstream of the later context (Fig. 1). The association between ISkpn31 and Tn4401 has been previously described [13].
Fig. 1

Genetic environment of blaKPC-2 gene found in representative strain Kpn8. Transposons Tn4001 and Tn5403 are represented by striped square boxes; inverted repeats are shown as a grey tall line. ISs (ISKpn7, ISKpn6 and ISKpn31) are shown with striped square boxes; arrows indicate transcriptional orientation; inverted repeats are shown as a grey tall line. blaKPC-2 gene is shown by grey arrow box.

Genetic environment of blaKPC-2 gene found in representative strain Kpn8. Transposons Tn4001 and Tn5403 are represented by striped square boxes; inverted repeats are shown as a grey tall line. ISs (ISKpn7, ISKpn6 and ISKpn31) are shown with striped square boxes; arrows indicate transcriptional orientation; inverted repeats are shown as a grey tall line. blaKPC-2 gene is shown by grey arrow box. The prevalence of CRE has increased substantially during the last decade. An increased prevalence of K. pneumoniae ST258 harbouring KPC was observed Argentina [14]. In addition, a KPC-producing K. pneumoniae isolate that belonged to a different ST, ST23, was also reported in the region [15]. The rapid increase and dissemination of the KPC carbapenemases in centres where major surgeries take place is of great concern. In this study we described the spread of K. pneumoniae blaKPC-2-positive strains in a neurosurgical centre. The genetic context and plasmid location of this carbapenemase has been determined. Because in all cases blaKPC-2 was plasmid located, we highlight the importance of searching for this gene and installing control measures to stop its dissemination.
  15 in total

Review 1.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

2.  First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea.

Authors:  Sung Kwan Hong; Dongeun Yong; Kyeongmi Kim; Sang Sook Hong; Seong Geun Hong; Tulgaa Khosbayar; Wonkeun Song; Kyoung Ho Roh; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

3.  Tn4401 carrying blaKPC is inserted within another insertion in pKpQIL and related plasmids.

Authors:  Sally R Partridge
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

Review 4.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

5.  Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina.

Authors:  S A Gomez; F G Pasteran; D Faccone; N Tijet; M Rapoport; C Lucero; O Lastovetska; E Albornoz; M Galas; R G Melano; A Corso; A Petroni
Journal:  Clin Microbiol Infect       Date:  2011-08-18       Impact factor: 8.067

Review 6.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

7.  Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.

Authors:  Ping Shen; Zeqing Wei; Yan Jiang; Xiaoxing Du; Shujuan Ji; Yunsong Yu; Lanjuan Li
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  First isolate of KPC-2-producing Klebsiella pneumonaie sequence type 23 from the Americas.

Authors:  Daniela Cejas; Liliana Fernández Canigia; Giovanna Rincón Cruz; Alan X Elena; Ivana Maldonado; Gabriel O Gutkind; Marcela A Radice
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

9.  Plasmid Dynamics in KPC-Positive Klebsiella pneumoniae during Long-Term Patient Colonization.

Authors:  Sean Conlan; Morgan Park; Clayton Deming; Pamela J Thomas; Alice C Young; Holly Coleman; Christina Sison; Rebecca A Weingarten; Anna F Lau; John P Dekker; Tara N Palmore; Karen M Frank; Julia A Segre
Journal:  MBio       Date:  2016-06-28       Impact factor: 7.867

10.  The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).

Authors:  Ross Overbeek; Robert Olson; Gordon D Pusch; Gary J Olsen; James J Davis; Terry Disz; Robert A Edwards; Svetlana Gerdes; Bruce Parrello; Maulik Shukla; Veronika Vonstein; Alice R Wattam; Fangfang Xia; Rick Stevens
Journal:  Nucleic Acids Res       Date:  2013-11-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.